| scholarly article | Q13442814 |
| P2093 | author name string | Martin MA | |
| Purcell DF | |||
| P2860 | cites work | High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR | Q22242246 |
| Regulation of human immunodeficiency virus env expression by the rev gene product | Q24646216 | ||
| A novel human immunodeficiency virus type 1 protein, tev, shares sequences with tat, env, and rev proteins | Q28246228 | ||
| HIV-1 regulator of virion expression (Rev) protein binds to an RNA stem-loop structure located within the Rev response element region | Q28256243 | ||
| HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease | Q28267375 | ||
| The HIV-1 rev trans-activator acts through a structured target sequence to activate nuclear export of unspliced viral mRNA | Q28279502 | ||
| rev protein of human immunodeficiency virus type 1 affects the stability and transport of the viral mRNA | Q28279513 | ||
| Differential usage of three exons generates at least five different mRNAs encoding human leukocyte common antigens | Q28647265 | ||
| Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone | Q29547734 | ||
| Importance of the nef gene for maintenance of high virus loads and for development of AIDS | Q29618369 | ||
| Regulation of tissue-specific alternative splicing: exon-specific cis-elements govern the splicing of leukocyte common antigen pre-mRNA | Q33561177 | ||
| Missense mutations in an infectious human immunodeficiency viral genome: functional mapping of tat and identification of the rev splice acceptor | Q33681763 | ||
| Steroid-receptor fusion of the human immunodeficiency virus type 1 Rev transactivator: mapping cryptic functions of the arginine-rich motif | Q33831166 | ||
| A tripartite HIV-1 tat-env-rev fusion protein | Q33918908 | ||
| HTLV-III expression and production involve complex regulation at the levels of splicing and translation of viral RNA. | Q34186306 | ||
| Nef protein of human immunodeficiency virus type 1: evidence against its role as a transcriptional inhibitor | Q34323995 | ||
| The rev (trs/art) protein of human immunodeficiency virus type 1 affects viral mRNA and protein expression via a cis-acting sequence in the env region | Q34544493 | ||
| Location of the trans-activating region on the genome of human T-cell lymphotropic virus type III. | Q34564460 | ||
| Alternative mRNA splicing | Q35237442 | ||
| Molecular profile of human immunodeficiency virus type 1 infection in symptomless patients and in patients with AIDS | Q36687307 | ||
| Control of retroviral RNA splicing through maintenance of suboptimal processing signals | Q36717739 | ||
| Importance of vpr for infection of rhesus monkeys with simian immunodeficiency virus. | Q36770468 | ||
| Alternative splice acceptor utilization during human immunodeficiency virus type 1 infection of cultured cells | Q36782518 | ||
| Characterization and expression of novel singly spliced RNA species of human immunodeficiency virus type 1 | Q36783395 | ||
| Env and Vpu proteins of human immunodeficiency virus type 1 are produced from multiple bicistronic mRNAs | Q36793376 | ||
| Human immunodeficiency virus rev protein recognizes a target sequence in rev-responsive element RNA within the context of RNA secondary structure | Q36796081 | ||
| Cloning and functional analysis of multiply spliced mRNA species of human immunodeficiency virus type 1 | Q36806618 | ||
| Mechanism of translation of monocistronic and multicistronic human immunodeficiency virus type 1 mRNAs | Q36808350 | ||
| Structure and expression of tat-, rev-, and nef-specific transcripts of human immunodeficiency virus type 1 in infected lymphocytes and macrophages | Q36810554 | ||
| In vitro mutagenesis identifies a region within the envelope gene of the human immunodeficiency virus that is critical for infectivity | Q36825840 | ||
| Temporal aspects of DNA and RNA synthesis during human immunodeficiency virus infection: evidence for differential gene expression | Q36830303 | ||
| The Rev protein of human immunodeficiency virus type 1 promotes polysomal association and translation of gag/pol and vpu/env mRNAs | Q36964078 | ||
| Biochemical Mechanisms of Constitutive and Regulated Pre-mRNA Splicing | Q37132263 | ||
| Elevated levels of mRNA can account for the trans-activation of human immunodeficiency virus | Q37412665 | ||
| Kinetics of expression of multiply spliced RNA in early human immunodeficiency virus type 1 infection of lymphocytes and monocytes | Q37528880 | ||
| Specific regulation of mRNA splicing in vitro by a peptide from HIV-1 Rev. | Q38332969 | ||
| Biochemical transfer of single-copy eucaryotic genes using total cellular DNA as donor | Q40170620 | ||
| Human growth hormone DNA sequence and mRNA structure: possible alternative splicing | Q40499454 | ||
| The role of the tnv protein and tnv RNA splicing signals in replication of HIV-1 IIIB isolates | Q41609512 | ||
| Identification of two novel human immunodeficiency virus type 1 splice acceptor sites in infected T cell lines | Q41614884 | ||
| Analysis of alternatively spliced human immunodeficiency virus type-1 mRNA species, one of which encodes a novel tat-env fusion protein | Q41657615 | ||
| Rev is necessary for translation but not cytoplasmic accumulation of HIV-1 vif, vpr, and env/vpu 2 RNAs | Q41686213 | ||
| Functional analysis of CAR, the target sequence for the Rev protein of HIV-1. | Q41757816 | ||
| Regulation by HIV Rev depends upon recognition of splice sites | Q41758926 | ||
| A novel gene of HIV-1, vpu, and its 16-kilodalton product | Q42656133 | ||
| Nucleic acid structure and expression of the human AIDS/lymphadenopathy retrovirus | Q43563098 | ||
| The rev gene product of the human immunodeficiency virus affects envelope-specific RNA localization | Q44022521 | ||
| The trans-activator gene of the human T cell lymphotropic virus type III is required for replication | Q44579665 | ||
| Secondary structure is the major determinant for interaction of HIV rev protein with RNA. | Q45129827 | ||
| Mutations within the human immunodeficiency virus type 1 gp160 envelope glycoprotein alter its intracellular transport and processing | Q45252128 | ||
| Regulation of mRNA accumulation by a human immunodeficiency virus trans-activator protein | Q45830211 | ||
| The HIV 'A' (sor) gene product is essential for virus infectivity | Q45847960 | ||
| A general method for rapid site-directed mutagenesis using the polymerase chain reaction. | Q48247178 | ||
| Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS | Q59057787 | ||
| Tissue-specific and allelic expression of the complement regulator CD46 is controlled by alternative splicing | Q61779875 | ||
| Interactions of small nuclear RNA's with precursor messenger RNA during in vitro splicing | Q64378031 | ||
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | virus | Q808 |
| infectivity | Q1662346 | ||
| alternative mRNA splicing, via spliceosome | Q21114084 | ||
| P304 | page(s) | 6365-6378 | |
| P577 | publication date | 1993-11-01 | |
| P1433 | published in | Journal of Virology | Q1251128 |
| P1476 | title | Alternative splicing of human immunodeficiency virus type 1 mRNA modulates viral protein expression, replication, and infectivity | |
| P478 | volume | 67 |
| Q37361258 | A 5'UTR-spliced mRNA isoform is specialized for enhanced HIV-2 gag translation |
| Q40375793 | A Cytoplasmic RNA Virus Alters the Function of the Cell Splicing Protein SRSF2. |
| Q52548171 | A Janus splicing regulatory element modulates HIV-1 tat and rev mRNA production by coordination of hnRNP A1 cooperative binding. |
| Q30381208 | A Naturally Occurring rev1-vpu Fusion Gene Does Not Confer a Fitness Advantage to HIV-1. |
| Q57086517 | A Rev–CBP80–eIF4AI complex drives Gag synthesis from the HIV-1 unspliced mRNA |
| Q24563281 | A bidirectional SF2/ASF- and SRp40-dependent splicing enhancer regulates human immunodeficiency virus type 1 rev, env, vpu, and nef gene expression |
| Q38961890 | A functional conserved intronic G run in HIV-1 intron 3 is critical to counteract APOBEC3G-mediated host restriction. |
| Q30407389 | A long-awaited structure is rev-ealed |
| Q42613411 | A minimal uORF within the HIV-1 vpu leader allows efficient translation initiation at the downstream env AUG. |
| Q35883049 | A model system for human cytomegalovirus-mediated modulation of human immunodeficiency virus type 1 long terminal repeat activity in brain cells |
| Q39882220 | A naturally arising mutation of a potential silencer of exon splicing in human immunodeficiency virus type 1 induces dominant aberrant splicing and arrests virus production |
| Q34970601 | A new generation of HIV vaccines |
| Q33556837 | A novel HIV-1-encoded microRNA enhances its viral replication by targeting the TATA box region |
| Q37331638 | A novel approach for inhibition of HIV-1 by RNA interference: counteracting viral escape with a second generation of siRNAs |
| Q34365863 | A novel function for Sam68: enhancement of HIV-1 RNA 3' end processing |
| Q33653774 | A rev1-vpu polymorphism unique to HIV-1 subtype A and C strains impairs envelope glycoprotein expression from rev-vpu-env cassettes and reduces virion infectivity in pseudotyping assays |
| Q90218662 | A scale-free analysis of the HIV-1 genome demonstrates multiple conserved regions of structural and functional importance |
| Q25255588 | A suboptimal 5' splice site downstream of HIV-1 splice site A1 is required for unspliced viral mRNA accumulation and efficient virus replication |
| Q35094890 | A truncated hnRNP A1 isoform, lacking the RGG-box RNA binding domain, can efficiently regulate HIV-1 splicing and replication |
| Q33236503 | Acetylated Tat regulates human immunodeficiency virus type 1 splicing through its interaction with the splicing regulator p32. |
| Q33911993 | An exonic splicing silencer downstream of the 3' splice site A2 is required for efficient human immunodeficiency virus type 1 replication |
| Q36637774 | An integration-defective U5 deletion mutant of human immunodeficiency virus type 1 reverts by eliminating additional long terminal repeat sequences |
| Q39222999 | An intronic G run within HIV-1 intron 2 is critical for splicing regulation of vif mRNA. |
| Q38705930 | Analysis of Competing HIV-1 Splice Donor Sites Uncovers a Tight Cluster of Splicing Regulatory Elements within Exon 2/2b |
| Q42654734 | Analysis of Jembrana disease virus mRNA transcripts produced during acute infection demonstrates a complex transcription pattern |
| Q35149006 | Analysis of human immunodeficiency virus type 1 gene expression in latently infected resting CD4+ T lymphocytes in vivo |
| Q37348552 | Analysis of human immunodeficiency virus type 1 transcriptional elongation in resting CD4+ T cells in vivo |
| Q35088292 | Analysis of multiply spliced transcripts in lymphoid tissue reservoirs of rhesus macaques infected with RT-SHIV during HAART |
| Q24498349 | Architecture and secondary structure of an entire HIV-1 RNA genome |
| Q33580330 | Argonaute proteins regulate HIV-1 multiply spliced RNA and viral production in a Dicer independent manner |
| Q35575811 | Balanced splicing at the Tat-specific HIV-1 3'ss A3 is critical for HIV-1 replication |
| Q50176880 | Behind the scenes of HIV-1 replication: Alternative splicing as the dependency factor on the quiet. |
| Q61443390 | Both anti-inflammatory and antiviral properties of novel drug candidate ABX464 are mediated by modulation of RNA splicing |
| Q35857341 | Both linear and discontinuous ribosome scanning are used for translation initiation from bicistronic human immunodeficiency virus type 1 env mRNAs |
| Q36289312 | CDK11 in TREX/THOC Regulates HIV mRNA 3' End Processing |
| Q39764495 | CDK13, a new potential human immunodeficiency virus type 1 inhibitory factor regulating viral mRNA splicing |
| Q39194586 | Can the HIV-1 splicing machinery be targeted for drug discovery? |
| Q37012917 | Cell type specificity and structural determinants of IRES activity from the 5' leaders of different HIV-1 transcripts |
| Q36798408 | Cell-associated HIV RNA: a dynamic biomarker of viral persistence |
| Q35837198 | Changes in the viral mRNA expression pattern correlate with a rapid rate of CD4+ T-cell number decline in human immunodeficiency virus type 1-infected individuals |
| Q37584186 | Chapter 1. Regulation of HIV-1 alternative RNA splicing and its role in virus replication |
| Q37271140 | Characterization of novel inhibitors of HIV-1 replication that function via alteration of viral RNA processing and rev function |
| Q36364322 | Characterization of staufen1 ribonucleoproteins by mass spectrometry and biochemical analyses reveal the presence of diverse host proteins associated with human immunodeficiency virus type 1. |
| Q38721805 | Characterizing HIV-1 Splicing by Using Next-Generation Sequencing |
| Q34309004 | Co-expression of HIV-1 virus-like particles and granulocyte-macrophage colony stimulating factor by GEO-D03 DNA vaccine |
| Q34671913 | Comparison of SIV and HIV-1 genomic RNA structures reveals impact of sequence evolution on conserved and non-conserved structural motifs |
| Q34260427 | Conserved stem-loop structures in the HIV-1 RNA region containing the A3 3' splice site and its cis-regulatory element: possible involvement in RNA splicing |
| Q33816167 | Contributions of viral splice sites and cis-regulatory elements to lentivirus vector function |
| Q35261679 | Converging strategies in expression of human complex retroviruses |
| Q39362365 | Defective HIV-1 Proviruses Are Expressed and Can Be Recognized by Cytotoxic T Lymphocytes, which Shape the Proviral Landscape. |
| Q35841354 | Defective accessory genes in a human immunodeficiency virus type 1-infected long-term survivor lacking recoverable virus |
| Q54225233 | Defining the molecular mechanisms of HIV-1 Tat secretion: PtdIns(4,5)P2 at the epicenter. |
| Q89086874 | Design of Gaussia luciferase-based bioluminescent stem-loop probe for sensitive detection of HIV-1 nucleic acids |
| Q96577275 | Determination of RNA structural diversity and its role in HIV-1 RNA splicing |
| Q33787285 | Development of multigene and regulated lentivirus vectors |
| Q35630437 | Differential Effects of Tra2ß Isoforms on HIV-1 RNA Processing and Expression |
| Q35143725 | Differential effect of CLK SR Kinases on HIV-1 gene expression: potential novel targets for therapy |
| Q41834943 | Differential effects of hnRNP D/AUF1 isoforms on HIV-1 gene expression. |
| Q33639362 | Diminished production of human immunodeficiency virus type 1 in astrocytes results from inefficient translation of gag, env, and nef mRNAs despite efficient expression of Tat and Rev |
| Q39608862 | Direct participation of Sam68, the 68-kilodalton Src-associated protein in mitosis, in the CRM1-mediated Rev nuclear export pathway |
| Q36672092 | Discovery and in vitro development of AIDS antiviral drugs as biopharmaceuticals |
| Q40410691 | Disruption of the putative splice acceptor site for SIV(mac239)Vif reveals tight control of SIV splicing and impaired replication in Vif non-permissive cells |
| Q21245209 | Dual effect of the SR proteins ASF/SF2, SC35 and 9G8 on HIV-1 RNA splicing and virion production |
| Q38212068 | Dynamic Post-Transcriptional Regulation of HIV-1 Gene Expression |
| Q36368754 | Dynamic regulation of HIV-1 mRNA populations analyzed by single-molecule enrichment and long-read sequencing. |
| Q35871860 | Dynamics and modulation of human immunodeficiency virus type 1 transcripts in vitro and in vivo |
| Q57490234 | Dynamics of the Gene Regulatory Network of HIV-1 and the Role of Viral Non-coding RNAs on Latency Reversion |
| Q36390805 | Ectopic expression of anti-HIV-1 shRNAs protects CD8(+) T cells modified with CD4ζ CAR from HIV-1 infection and alleviates impairment of cell proliferation |
| Q40704048 | Efficient transcription through an intron requires the binding of an Sm-type U1 snRNP with intact stem loop II to the splice donor |
| Q47094347 | Elucidating the in vivo interactome of HIV-1 RNA by hybridization capture and mass spectrometry |
| Q52592924 | Emerging Roles of N6-Methyladenosine on HIV-1 RNA Metabolism and Viral Replication. |
| Q21133769 | Engineering HIV-1-resistant T-cells from short-hairpin RNA-expressing hematopoietic stem/progenitor cells in humanized BLT mice |
| Q61447142 | Epitranscriptomics: Correlation of N6-methyladenosine RNA methylation and pathway dysregulation in the hippocampus of HIV transgenic rats |
| Q35034904 | Evaluation of alignment algorithms for discovery and identification of pathogens using RNA-Seq |
| Q34416441 | Excessive RNA Splicing and Inhibition of HIV-1 Replication Induced by Modified U1 Small Nuclear RNAs |
| Q49674917 | Experiment Design for Early Molecular Events in HIV Infection. |
| Q92071667 | Expression Level of HIV-1 Vif Can Be Fluctuated by Natural Nucleotide Variations in the vif-Coding and Regulatory SA1D2prox Sequences of the Proviral Genome |
| Q35549754 | Expression and reactivation of HIV in a chemokine induced model of HIV latency in primary resting CD4+ T cells |
| Q33635315 | Expression of Herpes Simplex Virus Thymidine Kinase/Ganciclovir by RNA Trans-Splicing Induces Selective Killing of HIV-Producing Cells. |
| Q36479939 | Feline immunodeficiency virus OrfA alters gene expression of splicing factors and proteasome-ubiquitination proteins |
| Q43577959 | Focal glomerulosclerosis in proviral and c-fms transgenic mice links Vpr expression to HIV-associated nephropathy |
| Q60927723 | Focus on Translation Initiation of the HIV-1 mRNAs |
| Q30374877 | Functional bottlenecks for generation of HIV-1 intersubtype Env recombinants. |
| Q34239843 | Gammaretroviral pol sequences act in cis to direct polysome loading and NXF1/NXT-dependent protein production by gag-encoded RNA. |
| Q36071452 | Gene activity in primary T cells infected with HIV89.6: intron retention and induction of genomic repeats. |
| Q35206871 | Gene transcription in HIV infection |
| Q92135927 | Genetic variation and function of the HIV-1 Tat protein |
| Q92623317 | Genome-Wide Analysis of Heterogeneous Nuclear Ribonucleoprotein (hnRNP) Binding to HIV-1 RNA Reveals a Key Role for hnRNP H1 in Alternative Viral mRNA Splicing |
| Q34249488 | Genomic HEXploring allows landscaping of novel potential splicing regulatory elements. |
| Q47548285 | Global synonymous mutagenesis identifies cis-acting RNA elements that regulate HIV-1 splicing and replication. |
| Q64071106 | Gymnotic Delivery of LNA Mixmers Targeting Viral SREs Induces HIV-1 mRNA Degradation |
| Q35829334 | HIV controls the selective packaging of genomic, spliced viral and cellular RNAs into virions through different mechanisms. |
| Q54214251 | HIV latency reversing agents act through Tat post translational modifications. |
| Q34033160 | HIV-1 Nef: a critical factor in viral-induced pathogenesis |
| Q30488459 | HIV-1 Recruits UPF1 but Excludes UPF2 to Promote Nucleocytoplasmic Export of the Genomic RNA. |
| Q36496484 | HIV-1 infection induces changes in expression of cellular splicing factors that regulate alternative viral splicing and virus production in macrophages |
| Q45372623 | HIV-1 pre-mRNA commitment to Rev mediated export through PSF and Matrin 3. |
| Q41705374 | HIV-1 splicing at the major splice donor site is restricted by RNA structure |
| Q40058710 | HIV-1 tolerates changes in A-count in a small segment of the pol gene |
| Q38234190 | HIV-1 translation and its regulation by cellular factors PKR and PACT. |
| Q64121615 | Highly Mutable Linker Regions Regulate HIV-1 Rev Function and Stability |
| Q37062073 | Human Immunodeficiency Virus Type 1 hnRNP A/B-Dependent Exonic Splicing Silencer ESSV Antagonizes Binding of U2AF65 to Viral Polypyrimidine Tracts |
| Q89522955 | Human Tat-specific factor 1 binds the HIV-1 genome and selectively transports HIV-1 RNAs |
| Q24320192 | Human immunodeficiency virus type 1 Nef binds directly to Lck and mitogen-activated protein kinase, inhibiting kinase activity |
| Q35835206 | Human immunodeficiency virus type 1 Nef protein inhibits activation pathways in peripheral blood mononuclear cells and T-cell lines. |
| Q35835327 | Human immunodeficiency virus type 1 cellular RNA load and splicing patterns predict disease progression in a longitudinally studied cohort. |
| Q34353549 | Human immunodeficiency virus type 1 incorporated with fusion proteins consisting of integrase and the designed polydactyl zinc finger protein E2C can bias integration of viral DNA into a predetermined chromosomal region in human cells |
| Q40667670 | Human immunodeficiency virus type 1 latency model for high-throughput screening |
| Q42800068 | Human p32 protein relieves a post-transcriptional block to HIV replication in murine cells |
| Q24599767 | Identification of Staufen in the human immunodeficiency virus type 1 Gag ribonucleoprotein complex and a role in generating infectious viral particles |
| Q42633019 | Identification of a novel splice acceptor in the HIV-1 genome: independent expression of the cytoplasmic tail of the envelope protein |
| Q39173758 | Identification of new and unusual rev and nef transcripts expressed by an HIV type 1 primary isolate |
| Q30413474 | Identification of new splice sites used for generation of rev transcripts in human immunodeficiency virus type 1 subtype C primary isolates |
| Q37607805 | Identification of small molecule modulators of HIV-1 Tat and Rev protein accumulation |
| Q40189962 | In vitro dimerization of human immunodeficiency virus type 1 (HIV-1) spliced RNAs |
| Q35066359 | In vivo SELEX of single-stranded domains in the HIV-1 leader RNA. |
| Q40739621 | Inhibition of HIV-1 replication by novel lentiviral vectors expressing transdominant Rev and HIV-1 env antisense |
| Q36850296 | Inhibition of HIV-1 transcription and replication by a newly identified cyclin T1 splice variant. |
| Q33827664 | Inhibition of splicing by serine-arginine rich protein 55 (SRp55) causes the appearance of partially spliced HIV-1 mRNAs in the cytoplasm |
| Q28083335 | Insights into the nuclear export of murine leukemia virus intron-containing RNA |
| Q43029724 | Insights into the selective activation of alternatively used splice acceptors by the human immunodeficiency virus type-1 bidirectional splicing enhancer |
| Q39804536 | Insulin-like growth factor II mRNA binding protein 1 modulates Rev-dependent human immunodeficiency virus type 1 RNA expression |
| Q33812392 | Integrase-lexA fusion proteins incorporated into human immunodeficiency virus type 1 that contains a catalytically inactive integrase gene are functional to mediate integration |
| Q89685622 | Integrated assessment of viral transcription, antigen presentation, and CD8+ T cell function reveal multiple limitations of class I selective HDACi during HIV-1 latency reversal |
| Q33340808 | Integration site selection by retroviral vectors: molecular mechanism and clinical consequences |
| Q28078564 | Interactions between the HIV-1 Unspliced mRNA and Host mRNA Decay Machineries |
| Q37194255 | Intracellular transport of human immunodeficiency virus type 1 genomic RNA and viral production are dependent on dynein motor function and late endosome positioning |
| Q52672265 | Intron retention in viruses and cellular genes: Detention, border controls and passports. |
| Q38635966 | Iron overload down-regulates the expression of the HIV-1 Rev cofactor eIF5A in infected T lymphocytes |
| Q35944232 | Lentiviral vector integration in the human genome induces alternative splicing and generates aberrant transcripts |
| Q38188271 | Life of psi: how full-length HIV-1 RNAs become packaged genomes in the viral particles |
| Q39783741 | Limited complementarity between U1 snRNA and a retroviral 5' splice site permits its attenuation via RNA secondary structure |
| Q30373903 | Long lasting control of viral rebound with a new drug ABX464 targeting Rev - mediated viral RNA biogenesis. |
| Q61796320 | Longitudinal HIV sequencing reveals reservoir expression leading to decay which is obscured by clonal expansion |
| Q36858478 | MS3D structural elucidation of the HIV-1 packaging signal |
| Q35004179 | Mathematical model of the Tat-Rev regulation of HIV-1 replication in an activated cell predicts the existence of oscillatory dynamics in the synthesis of viral components |
| Q37131965 | Mechanisms employed by retroviruses to exploit host factors for translational control of a complicated proteome. |
| Q34063962 | Molecular genetics and target site specificity of retroviral integration |
| Q33565157 | Multi-Faceted Post-Transcriptional Functions of HIV-1 Rev. |
| Q38379102 | Multiple Origins of Virus Persistence during Natural Control of HIV Infection |
| Q38316167 | Multiple copies of the Mason-Pfizer monkey virus constitutive RNA transport element lead to enhanced HIV-1 Gag expression in a context-dependent manner. |
| Q43902042 | Mutational analysis of the internal membrane proximal domain of the HIV glycoprotein C-terminus. |
| Q34138829 | Mutations in matrix and SP1 repair the packaging specificity of a Human Immunodeficiency Virus Type 1 mutant by reducing the association of Gag with spliced viral RNA |
| Q36811895 | Natural Single-Nucleotide Variations in the HIV-1 Genomic SA1prox Region Can Alter Viral Replication Ability by Regulating Vif Expression Levels |
| Q37713854 | Natural single-nucleotide polymorphisms in the 3' region of the HIV-1 pol gene modulate viral replication ability |
| Q36633545 | Naturally occurring genotypes of the human immunodeficiency virus type 1 long terminal repeat display a wide range of basal and Tat-induced transcriptional activities. |
| Q38269023 | Nef of HIV-1 interacts directly with calcium-bound calmodulin |
| Q36540041 | Negative and positive mRNA splicing elements act competitively to regulate human immunodeficiency virus type 1 vif gene expression |
| Q41775010 | New way of regulating alternative splicing in retroviruses: the promoter makes a difference |
| Q22252434 | Newly identified host factors modulate HIV replication |
| Q89685656 | Next Generation Sequencing in a direct model of HIV infection reveals important parallels and differences to in vivo reservoir dynamics |
| Q35219990 | Next-generation sequencing reveals HIV-1-mediated suppression of T cell activation and RNA processing and regulation of noncoding RNA expression in a CD4+ T cell line |
| Q34381398 | Nuclear transport of human immunodeficiency virus type 1, visna virus, and equine infectious anemia virus Rev proteins: identification of a family of transferable nuclear export signals. |
| Q59131677 | Nucleolar Localization of HIV-1 Rev Is Required, Yet Insufficient for Production of Infectious Viral Particles |
| Q43727649 | Numerical modelling of the perturbation of HIV-1 during combination anti-retroviral therapy. |
| Q91804744 | On the generation of the MSD-Ѱ class of defective HIV proviruses |
| Q41851074 | On the role of four small hairpins in the HIV-1 RNA genome |
| Q43124783 | Optimization of human immunodeficiency virus type 1 envelope glycoproteins with V1/V2 deleted, using virus evolution |
| Q24291820 | Organization of the human tarbp2 gene reveals two promoters that are repressed in an astrocytic cell line |
| Q38982524 | Pokeweed antiviral protein alters splicing of HIV-1 RNAs, resulting in reduced virus production |
| Q36857076 | Posttranscriptional control of HIV-1 and other retroviruses and its practical applications |
| Q37261090 | Posttranscriptional regulation of retroviral gene expression: primary RNA transcripts play three roles as pre-mRNA, mRNA, and genomic RNA. |
| Q36554054 | Presence of exon splicing silencers within human immunodeficiency virus type 1 tat exon 2 and tat-rev exon 3: evidence for inhibition mediated by cellular factors |
| Q30450216 | Presence of negative and positive cis-acting RNA splicing elements within and flanking the first tat coding exon of human immunodeficiency virus type 1 |
| Q47554842 | Production of HIV-1 vif mRNA Is Modulated by Natural Nucleotide Variations and SLSA1 RNA Structure in SA1D2prox Genomic Region |
| Q37272747 | Prolonged persistence of a novel replication-defective HIV-1 variant in plasma of a patient on suppressive therapy |
| Q40089005 | Puralpha as a cellular co-factor of Rev/RRE-mediated expression of HIV-1 intron-containing mRNA. |
| Q39084005 | RNA helicase MOV10 functions as a co-factor of HIV-1 Rev to facilitate Rev/RRE-dependent nuclear export of viral mRNAs |
| Q35652119 | RNA interference approaches for treatment of HIV-1 infection |
| Q33854295 | RNA splicing at human immunodeficiency virus type 1 3' splice site A2 is regulated by binding of hnRNP A/B proteins to an exonic splicing silencer element |
| Q28262840 | RNA structure modulates splicing efficiency at the human immunodeficiency virus type 1 major splice donor |
| Q39816401 | RNAi-mediated inhibition of HIV-1 by targeting partially complementary viral sequences |
| Q42148114 | RRE-deleting self-inactivating and self-activating HIV-1 vectors for improved safety |
| Q37538638 | Randomized Trial of Food Effect on Pharmacokinetic Parameters of ABX464 Administered Orally to Healthy Male Subjects |
| Q37204580 | Regulation of Vif mRNA splicing by human immunodeficiency virus type 1 requires 5' splice site D2 and an exonic splicing enhancer to counteract cellular restriction factor APOBEC3G |
| Q34546893 | Regulation of alternative RNA splicing by exon definition and exon sequences in viral and mammalian gene expression |
| Q33640055 | Regulation of virus release by the macrophage-tropic human immunodeficiency virus type 1 AD8 isolate is redundant and can be controlled by either Vpu or Env. |
| Q33839005 | Repair of a Rev-minus human immunodeficiency virus type 1 mutant by activation of a cryptic splice site. |
| Q36546903 | Replication of human immunodeficiency virus type 1 from entry to exit |
| Q36447124 | Retrovirus translation initiation: Issues and hypotheses derived from study of HIV-1 |
| Q34033155 | Rev protein and its cellular partners |
| Q35634169 | Rev-dependent lentiviral expression vector |
| Q35079162 | Rev-ing up post-transcriptional HIV-1 RNA expression |
| Q39577905 | Ribosomal scanning on the 5'-untranslated region of the human immunodeficiency virus RNA genome |
| Q34351276 | Robust growth of human immunodeficiency virus type 1 (HIV-1) |
| Q35468374 | Role of HIV-1 RNA and protein determinants for the selective packaging of spliced and unspliced viral RNA and host U6 and 7SL RNA in virus particles |
| Q37033364 | Role of cellular RNA processing factors in human immunodeficiency virus type 1 mRNA metabolism, replication, and infectivity |
| Q35040210 | Roles of the linker region of RNA helicase A in HIV-1 RNA metabolism |
| Q39646678 | SR proteins and hnRNP H regulate the splicing of the HIV-1 tev-specific exon 6D. |
| Q35760531 | SRSF1 RNA Recognition Motifs Are Strong Inhibitors of HIV-1 Replication. |
| Q36975224 | Selective translational repression of HIV-1 RNA by Sam68DeltaC occurs by altering PABP1 binding to unspliced viral RNA |
| Q34351941 | Selectively reduced tat mRNA heralds the decline in productive human immunodeficiency virus type 1 infection in monocyte-derived macrophages |
| Q36063873 | Sequence Analysis of In Vivo-Expressed HIV-1 Spliced RNAs Reveals the Usage of New and Unusual Splice Sites by Viruses of Different Subtypes. |
| Q33649436 | Serine- and Arginine-rich Proteins 55 and 75 (SRp55 and SRp75) Induce Production of HIV-1 vpr mRNA by Inhibiting the 5′-Splice Site of Exon 3 |
| Q45784451 | Single cell transcript analysis of human immunodeficiency virus gene expression in the transition from latent to productive infection |
| Q27319151 | Single-Cell and Single-Cycle Analysis of HIV-1 Replication |
| Q24682936 | Small interfering RNAs against the TAR RNA binding protein, TRBP, a Dicer cofactor, inhibit human immunodeficiency virus type 1 long terminal repeat expression and viral production |
| Q36518316 | Solution Structure of the HIV-1 Intron Splicing Silencer and Its Interactions with the UP1 Domain of Heterogeneous Nuclear Ribonucleoprotein (hnRNP) A1 |
| Q24807291 | Splicing of human immunodeficiency virus RNA is position-dependent suggesting sequential removal of introns from the 5' end |
| Q33824324 | Splicing regulatory elements within tat exon 2 of human immunodeficiency virus type 1 (HIV-1) are characteristic of group M but not group O HIV-1 strains. |
| Q97528833 | Stress proteins: the biological functions in virus infection, present and challenges for target-based antiviral drug development |
| Q38367292 | Targeting the HIV RNA genome: high-hanging fruit only needs a longer ladder |
| Q92240525 | Tat IRES modulator of tat mRNA (TIM-TAM): a conserved RNA structure that controls Tat expression and acts as a switch for HIV productive and latent infection |
| Q33455685 | Tat-SF1 is not required for Tat transactivation but does regulate the relative levels of unspliced and spliced HIV-1 RNAs |
| Q40628737 | The 0.3-kb fragment containing the R-U5-5'leader sequence of Friend murine leukemia virus influences the level of protein expression from spliced mRNA. |
| Q39237000 | The Alphabet Soup of HIV Reservoir Markers |
| Q34469824 | The HIV-1 Rev protein enhances encapsidation of unspliced and spliced, RRE-containing lentiviral vector RNA |
| Q30300217 | The HIV-1 Rev response element (RRE) adopts alternative conformations that promote different rates of virus replication |
| Q54216806 | The HIV-1 Tat protein enhances splicing at the major splice donor site. |
| Q45219002 | The HIV-1 major splice donor D1 is activated by splicing enhancer elements within the leader region and the p17-inhibitory sequence |
| Q92881205 | The Impact of Cellular Proliferation on the HIV-1 Reservoir |
| Q28076985 | The Life-Cycle of the HIV-1 Gag-RNA Complex |
| Q35888172 | The Vif and Gag proteins of human immunodeficiency virus type 1 colocalize in infected human T cells |
| Q35854386 | The envelope glycoprotein of human immunodeficiency virus type 2 enhances viral particle release: a Vpu-like factor? |
| Q33778676 | The exon splicing silencer in human immunodeficiency virus type 1 Tat exon 3 is bipartite and acts early in spliceosome assembly |
| Q32061728 | The expression of the essential nuclear splicing factor SC35 is altered by human immunodeficiency virus infection |
| Q38356070 | The hepatitis B virus posttranscriptional regulatory element is composed of two subelements |
| Q34362436 | The leader of the HIV-1 RNA genome forms a compactly folded tertiary structure |
| Q34667412 | The retrovirus RNA trafficking granule: from birth to maturity |
| Q34361775 | The role of overlapping U1 and U11 5' splice site sequences in a negative regulator of splicing |
| Q30440740 | The secondary structure of the human immunodeficiency virus type 1 transcript modulates viral splicing and infectivity |
| Q35220043 | The strength of the HIV-1 3' splice sites affects Rev function. |
| Q33700143 | The transcriptional transactivator Tat selectively regulates viral splicing. |
| Q38732658 | Thermodynamic and phylogenetic insights into hnRNP A1 recognition of the HIV-1 exon splicing silencer 3 element |
| Q33489159 | Thermodynamic profiling of HIV RREIIB RNA-zinc finger interactions |
| Q36607087 | Tra2-mediated recognition of HIV-1 5' splice site D3 as a key factor in the processing of vpr mRNA |
| Q30439325 | Trafficking through the Rev/RRE pathway is essential for efficient inhibition of human immunodeficiency virus type 1 by an antisense RNA derived from the envelope gene |
| Q39611742 | Transcription of preintegrated HIV-1 cDNA modulates cell surface expression of major histocompatibility complex class I via Nef. |
| Q34071895 | Transcription through the HIV-1 nucleosomes: effects of the PBAF complex in Tat activated transcription |
| Q34030804 | Transcriptional and posttranscriptional regulation of HIV-1 gene expression |
| Q26801493 | Translational Control of the HIV Unspliced Genomic RNA |
| Q33832420 | Translational regulation of HIV-1 replication by HIV-1 Rev cellular cofactors Sam68, eIF5A, hRIP, and DDX3. |
| Q37247695 | Treatment with the fusion inhibitor enfuvirtide influences the appearance of mutations in the human immunodeficiency virus type 1 regulatory protein rev. |
| Q33653701 | U1 small nuclear ribonucleoprotein and splicing inhibition by the rous sarcoma virus negative regulator of splicing element. |
| Q35828687 | Unique insertion sequence and pattern of CD4 expression in variants selected with immunotoxins from human immunodeficiency virus type 1-infected T cells. |
| Q39101871 | Unusual Fusion Proteins of HIV-1 |
| Q40198557 | Use of modified U1 snRNAs to inhibit HIV-1 replication |
| Q34983999 | Utilization of host SR protein kinases and RNA-splicing machinery during viral replication |
| Q33850355 | Vaccination with attenuated simian immunodeficiency virus by DNA inoculation |
| Q38739273 | Various plus unique: Viral protein U as a plurifunctional protein for HIV-1 replication |
| Q47548192 | What do we measure when we measure cell-associated HIV RNA. |
| Q35864679 | cis-acting elements in human immunodeficiency virus type 1 RNAs direct viral transcripts to distinct intranuclear locations. |
| Q33782866 | gag, vif, and nef genes contribute to the homologous viral interference induced by a nonproducer human immunodeficiency virus type 1 (HIV-1) variant: identification of novel HIV-1-inhibiting viral protein mutants |
| Q42621995 | hnRNP A1 controls HIV-1 mRNA splicing through cooperative binding to intron and exon splicing silencers in the context of a conserved secondary structure |
| Q35778000 | hnRNP E1 and E2 have distinct roles in modulating HIV-1 gene expression |
| Q58604866 | mA: Widespread regulatory control in virus replication |
Search more.